The role of intercellular adhesion molecule-1 (ICAM-1) and its soluble form (sICAM-1) in chronic airway inflammation;Rola cza̧steczek adhezji miȩdzykomórkowej (ICAM-1) i ich rozpuszczalnej formy (sICAM-1) w rozwoju przewlekłego zapalenia alergicznego

Polski Merkuriusz Lekarski

Volumn 16, Issue 92, 2004, Pages 179-182

  Grzelewska Rzymowska, Iwona ^a,b   Pietrzkowicz, Magdalena ^a  

^a UM ^*  (Poland)

^b Klinika Gruzlicy i Chorob Pluc   (Poland)

Author keywords

Allergic inflammation; Allergic rhinitis; Asthma; Intercellular adhesion molecule

Indexed keywords

CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; SOLUBLE INTERCELLULAR ADHESION MOLECULE 1; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ANTIGEN EXPRESSION; ASTHMA; BRONCHUS BIOPSY; CHRONIC INFLAMMATION; ENDOTHELIUM CELL; EOSINOPHILIA; EPITHELIUM CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LUNG LAVAGE; MAST CELL; NEUTROPHIL CHEMOTAXIS; NOSE MUCUS; PROVOCATION TEST; REVIEW; T LYMPHOCYTE ACTIVATION; CHRONIC DISEASE; INFLAMMATION; METABOLISM; NOSE MUCOSA; PATHOPHYSIOLOGY; PERENNIAL RHINITIS; RESPIRATORY TRACT MUCOSA; SOLUBILITY;

ASTHMA; CHRONIC DISEASE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; NASAL MUCOSA; RESPIRATORY MUCOSA; RHINITIS, ALLERGIC, PERENNIAL; SOLUBILITY;

EID: 1642302109     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Bentley A.M. i wsp.: Expression of endothelial and leukocyte adhesion molecules intercellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma. J. Allergy Clin. Immunol., 1993, 92, 857-68.
2. Bochner B.S. i wsp.: Differences between human eosinophil and neutrophil adhesion to endothelial cell in the function and expression of sialic acid-containing conterligands for E-selectin. J. Immunol., 1994, 152, 774-782.
3. Braunsahl G-J. i wsp.: Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J. Allergy Clin. Immunol., 2001, 107, 469-476.
4. Cengizlier R. i wsp.: Circulating ICAM-1 levels in bronchial asthma and the effect of inhaled corticosteroids. Ann. Allergy Asthma Immunol., 2000, 84, 539-541.
5. Chihara J. i wsp.: Degranulation of eosinophils mediated by intercellular adhesion molecule-1 and its ligands is involved in adhesion molecule expression on endothelial cells-selective induction of VCAM-1. J. Allergy Clin. Immunol., 1999, 103, S452-S456.
6. Chihara J. i wsp.: Signaling through the beta 2 integrin prolongs eosinophil survival. J. Allergy Clin. Immunol., 2000, 106, S99-S103.
7. Chihara J. i wsp.: Soluble ICAM-1 in sputum of patients with bronchial asthma. Lancet, 1994, 343, 1108 (Letter).
8. Ciprandi G. i wsp.: Allergen specific challenge induces intercellular adhesion molecule-1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Am. J. Respir. Crit. Care Med., 1994, 150, 1653-1659.
9. Demoly P. i wsp.: ICAM-1 expression in uppre respiratory mucosa is defferentially related to eosinophil and neutrophil inflammation according to the allergic status. Clin. Exp. Allergy, 1998, 28, 731-738.
10. Gonokami Y. i wsp.: Circulating intracellular adhesion molecule-1 concentrations following bronchial provocation in atopic asthma. Int. Arch. Allergy Immunol., 1997, 112, 386-391.
11. Gosset P. i wsp.: Expression of E-selectin, ICAM-1, VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients. Int. Arch. Allergy Immunol., 1995, 106, 69-77.
12. Gundel R.H. i wsp.: The role of intercellular adhesion molecule-1 in airway inflammation. Clin. Exp. Allergy, 1992, 22, 569-575.
13. Hashimoto S. i wsp.: Elevated levels of soluble ICAM-1 in sera from patients with bronchial asthma. Allergy, 1993, 48, 370-372.
14. Hirata N. i wsp.: Allergen exposure induces the expression of endothelial adhesion molecules in passively sensitized human bronchus, time course and the role of cytokines. Am. J. Respir. Cell Mol. Biol., 1998, 18, 12-20.
15. Kato M. i wsp.: Soluble ICAM-1 as a regulator of nasal allergic reaction under natural allergen provocation. Clin. Exp. Allergy, 1995, 25, 744-748.
16. Louis R. i wsp.: ICAM-1 expression and eosinophil chemotactic activity in asthmatic sputum. Am. J. Respir. Crit. Care Med., 1997, 155, 446-472.
17. Luscinskas F.W. i wsp.: Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial leucocyte adhesion molecule-1 and intercellular adhesion molecule-1. J. Immunol., 1991, 146, 1617-1625.
18. Montefort S. i wsp.: Bronchial biopsy evidence for leukocyte infiltration and upregulation for leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J. Clin. Invest., 1994, 93, 1411-1421.
19. Montefort S. i wsp.: Circulating adhesion molecules in asthma. Am. J. Respir. Crit. Care Med., 1994, 149, 1149-1152.
20. Montefort S. i wsp.: Intercellular adhesion molecule-1 (ICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in the bronchial mucosa of normal and asthmatic subjects. Eur. Respir. J., 1992, 5, 815-823.
21. Montefort S. i wsp.: Leucocyte-endothelial adhesion molecules and their role in bronchial asthma and allergic rhinitis. Eur. Respir. J., 1993, 6, 1044-1054.
22. Oh J.W. i wsp.: Expression of ICAM-1 on conjuctival epithelium and ECP in tears and serum from children with allergic conjunctivitis. Ann. Allergy Asthma Immunol., 1999, 82, 579-585.
23. Passalacqua G. i wsp.: The relationship between clinical efficacy of specific immunotherapy and serum intercellular adhesion molecule-1 levels. J. Investig. Allergol. Clin. Immunol., 1998, 8, 123-124.
24. Pietrzkowicz M. i wsp.: Nadreaktywność oskrzeli, caøkowite stȩżenie IgE oraz stȩżenia sICAM-1 i TNFα w surowicy chorych na sezonowy alergiczny nieżyt nosa. Pneum. Alergol. Pol., 2002, suppl 1, 128-129.
25. Ricca V. i wsp.: Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis. J. Allergy Clin. Immunol., 1999, 104, 54-57.
26. Schleimer R.P. i wsp.: The role of adhesion molecules in allergic inflammation and their suitability as targets of antiallergic therapy. Clin. Exp. Allergy, 1998, 28 (suppl. 3), 15-23.
27. Seth R. i wsp.: Circulating ICAM-1 isoforms, diagnostic prospects for inflammatory and immune disorders. Lancet, 1991, 338, 83-84.
28. Shi H.Z. i wsp.: Inhaled IL-5 increases concentrations of soluble intracellular adhesion molecule-1 in sputum from atopic asthmatic subjects. J. Allergy Clin. Immunol., 1999, 103, 463-467.
29. Shiota Y. i wsp.: Serum levels of soluble ICAM-1 in asthmatic patients. Abstract Arerugi, 1993, 142, 1782-1787.
30. Stelmach I. i wsp.: Markers of allergic inflammation in peripheral blood of children with asthma after treatment with inhaled triamcinolone acetonide. Ann. Allergy Asthma Immunol., 2001, 87, 319-326.
31. Takahaski N. i wsp.: Soluble intracellular adhesion molecule-1 in brochoalveolar lavage fluid of allergic subjects following segmental antigen challange. Am. J. Respir. Crit. Care Med., 1994, 150, 704-709.
32. Vennegoor C.J.G.M. i wsp.: Role of LFA-1 nad VLA-4 in the adhesion of cloned normal and LFA-1 (CD11/CD18)-deficient T-cells to cultured endothelial cells. J. Immunol., 1992, 148, 1093-1101.